Research progress on neutralizing antibodies for the treatment of severe respiratory syncytial virus infection in children
10.3760/cma.j.issn.1673-4912.2024.05.009
- VernacularTitle:中和抗体治疗儿童重症呼吸道合胞病毒感染的研究进展
- Author:
Yuan GAO
1
;
Jiujun LI
Author Information
1. 中国医科大学附属盛京医院儿内科,沈阳 110004
- Keywords:
Neutralizing antibody;
Respiratory syncytial virus;
Virus pneumonia;
Severe;
Children
- From:
Chinese Pediatric Emergency Medicine
2024;31(5):363-366
- CountryChina
- Language:Chinese
-
Abstract:
Respiratory syncytial virus(RSV)is the leading cause of severe lower respiratory tract infections in young children,with a high rate of hospitalization and mortality.Specific anti-RSV therapies have not been reported.The structure of RSV is such that it is mainly F and G proteins in the surface that act as adhesion and invade the host cells.Therefore,monoclonal antibodies against F and G proteins with neutralization sites are currently being developed. This review summarized the mechanism, prevention and treatment of RSV based on neutralizing antibody.